Metraipolis › archive › dc_ef0870c3ee45

ERO1A as a novel biomarker for risk stratification and immunotherapeutic guidance in early-stage lung adenocarcinoma — Europe PMC PMID:42328676

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42328676
DOI
10.7717/peerj.21347
License (as archived)
solo-consultazione
Archived
2026-10-19T08:56:02.498Z
SHA-256 of the archived text
78859b4116a1c9cb69fe329c891a5ce7f8368bc4a316a060ade22477a1a43054
Stable URL of this page
https://metraipolis.com/documento/dc_ef0870c3ee45

How to cite

ERO1A as a novel biomarker for risk stratification and immunotherapeutic guidance in early-stage lung adenocarcinoma — Europe PMC PMID:42328676 — Europe PMC (en), https://europepmc.org/article/MED/42328676 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef0870c3ee45 (Metraipolis archive dc_ef0870c3ee45, sha256 78859b4116a1c9cb69fe329c891a5ce7f8368bc4a316a060ade22477a1a43054)
BibTeX
@misc{dcef0870c3ee45,
  title = {ERO1A as a novel biomarker for risk stratification and immunotherapeutic guidance in early-stage lung adenocarcinoma — Europe PMC PMID:42328676},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42328676},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef0870c3ee45; sha256 78859b4116a1c9cb69fe329c891a5ce7f8368bc4a316a060ade22477a1a43054},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42328676. Agents can read the archived copy with the MCP tool read_document.